查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1554352

2024-2032 年日本寡核苷酸合成市场报告（按产品、应用（PCR 引子、PCR 测定和麵板、定序、DNA 微阵列、萤光原位杂交、反义寡核苷酸等）、最终用途和区域）

Japan Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格
简介目录

日本寡核苷酸合成市场规模预计在 2024 年至 2032 年期间将呈现 11.70% 的成长率 (CAGR)。新型治疗策略的广泛采用，加上生物资讯学和资料科学的显着成长，主要推动了市场的成长。

寡核苷酸合成是建构具有特定序列的短 DNA 或 RNA 分子（称为寡核苷酸）的过程。这些序列的长度可以从几个碱基到大约 200 个核苷酸不等。该过程通常在受控实验室环境中透过化学合成进行，通常利用固相亚磷酰胺化学。在这种方法中，核苷酸被顺序添加到不断增长的链中，每次添加都涉及一系列化学反应。这项技术使科学家能够为一系列应用创建客製化的寡核苷酸，包括基因合成、聚合酶炼式反应 (PCR)、CRISPR-Cas9 等基因编辑工具和分子诊断测试。寡核苷酸合成的进步极大地加速了基因组学和分子生物学的研究，在医学和生物学研究的众多突破中发挥了关键作用。

日本寡核苷酸合成市场趋势：

日本寡核苷酸市场的主要动力是人口中遗传疾病发生率的增加。这就需要探索新的治疗方法，其中基于寡核苷酸的疗法发挥重要作用。例如，利用小干扰 RNA (siRNA) 和反义寡核苷酸的疗法正在研究并应用于治疗杜氏肌肉营养不良症和脊髓性肌肉萎缩症等遗传性疾病。因此，遗传疾病的日益普及不仅在日本而且在更广泛的范围内推动了需求。此外，生物资讯学和资料科学的扩展直接影响寡核苷酸合成领域。分析广泛基因组数据集的能力不断增强，对创新寡核苷酸的合成产生了更大的需求，从而对市场产生了积极影响。此外，寡核苷酸，特别是反义寡核苷酸，已被证明在表观遗传学研究和治疗中有效，促进基因表现调节并有助于良好的市场前景。此外，製药公司、生技公司和研究机构之间的合作和伙伴关係已成为推动遗传疾病寡核苷酸疗法的开发和商业化的关键驱动力。这些合作预计将在预测期内推动区域市场的发展。

日本寡核苷酸合成市场细分：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2024-2032 年国家层级的预测。我们的报告根据产品、应用和最终用途对市场进行了分类。

产品见解：

  • 合成寡核苷酸产品
  • 试剂
  • 装置
  • 服务

该报告根据产品提供了详细的市场细分和分析。这包括合成的寡核苷酸产品、试剂、设备和服务。

应用见解：

  • PCR引子
  • PCR 检测与试剂盒
  • 定序
  • DNA微阵列
  • 萤光原位杂交 (FISH)
  • 反义寡核苷酸
  • 其他的

报告还提供了基于应用程式的详细市场细分和分析。这包括 PCR 引子、PCR 检测和组合、定序、DNA 微阵列、萤光原位杂交 (FISH)、反义寡核苷酸等。

最终用途见解：

  • 製药和生物技术公司
  • 医院和诊断实验室
  • 学术研究机构

该报告根据最终用途提供了详细的市场细分和分析。这包括製药和生物技术公司、医院和诊断实验室以及学术研究机构。

区域见解：

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

该报告还对所有主要区域市场进行了全面分析，包括关东地区、关西/近畿地区、中部/中部地区、九州冲绳地区、东北地区、中国地区、北海道地区和四国地区。

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 到目前为止，日本寡核苷酸合成市场的表现如何，未来几年将如何表现？
  • COVID-19对日本寡核苷酸合成市场有何影响？
  • 日本寡核苷酸合成市场依产品划分是怎样的？
  • 日本寡核苷酸合成市场在应用上的细分如何？
  • 日本寡核苷酸合成市场以最终用途划分是怎样的？
  • 日本寡核苷酸合成市场价值链的各个阶段是什么？
  • 日本寡核苷酸合成的关键驱动因素和挑战是什么？
  • 日本寡核苷酸合成市场的结构如何？
  • 日本寡核苷酸合成市场的竞争程度如何？

本报告回答的关键问题：

  • 到目前为止，日本寡核苷酸合成市场的表现如何，未来几年将如何表现？
  • COVID-19对日本寡核苷酸合成市场有何影响？
  • 日本寡核苷酸合成市场依产品划分是怎样的？
  • 日本寡核苷酸合成市场在应用上的细分如何？
  • 日本寡核苷酸合成市场以最终用途划分是怎样的？
  • 日本寡核苷酸合成市场价值链的各个阶段是什么？
  • 日本寡核苷酸合成的关键驱动因素和挑战是什么？
  • 日本寡核苷酸合成市场的结构如何？
  • 日本寡核苷酸合成市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本寡核苷酸合成市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本寡核苷酸合成市场格局

  • 历史与当前市场趋势（2018-2023）
  • 市场预测（2024-2032）

第 6 章：日本寡核苷酸合成市场 - 细分：依产品分类

  • 合成寡核苷酸产品
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 试剂
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 装置
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 服务
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 7 章：日本寡核苷酸合成市场 - 细分：依应用分类

  • PCR引子
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • PCR 检测与试剂盒
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 定序
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • DNA微阵列
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 萤光原位杂交 (FISH)
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 反义寡核苷酸
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

CHAPTER 8 : 日本寡核苷酸合成市场 - 分裂：最终用途别

  • 製药和生物技术公司
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 医院和诊断实验室
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 学术研究机构
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 9 章：日本寡核苷酸合成市场 - 细分：按地区

  • 关东地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 关西/近畿地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 中部/中部地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 九州·冲绳地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 东北部地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 中国地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 北海道地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）
  • 四国地区
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔：按产品
    • 市场区隔：按应用
    • 市场区隔：最终用途别
    • 关键参与者
    • 市场预测（2024-2032）

第 10 章：日本寡核苷酸合成市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 11 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

此处未提供公司名称，因为这是目录范例。报告中提供了完整的清单。

第 12 章：日本寡核苷酸合成市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章：附录

简介目录
Product Code: SR112024A18546

Japan oligonucleotide synthesis market size is projected to exhibit a growth rate (CAGR) of 11.70% during 2024-2032. The widespread adoption of novel therapeutic strategies, coupled with significant growth of bioinformatics and data science, is primarily driving the market growth.

Oligonucleotide synthesis is the procedure for constructing short DNA or RNA molecules, known as oligonucleotides, with a specific sequence. These sequences can vary in length from just a few bases to approximately 200 nucleotides. This process is typically carried out through chemical synthesis in a controlled laboratory setting, often utilizing solid-phase phosphoramidite chemistry. In this approach, nucleotides are sequentially added to a growing chain, with each addition involving a series of chemical reactions. This technology allows scientists to create tailor-made oligonucleotides for a range of applications, including gene synthesis, polymerase chain reaction (PCR), gene editing tools like CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have greatly accelerated research in genomics and molecular biology, playing a pivotal role in numerous breakthroughs in medical and biological research.

Japan Oligonucleotide Synthesis Market Trends:

The Japanese market for oligonucleotides is primarily propelled by the increasing incidence of genetic diseases within the population. This necessitates the exploration of novel therapeutic approaches, with a significant role being played by oligonucleotide-based therapies. For example, therapies utilizing small interfering RNAs (siRNAs) and antisense oligonucleotides are being researched and applied in the treatment of genetic disorders like Duchenne muscular dystrophy and spinal muscular atrophy. Consequently, the growing prevalence of genetic diseases is driving demand not only in Japan but also on a wide scale. Furthermore, the expansion of bioinformatics and data science is directly impacting the oligonucleotide synthesis sector. The increasing capacity to analyze extensive genomic datasets is positively influencing the market by generating greater demand for the synthesis of innovative oligonucleotides. Additionally, oligonucleotides, particularly antisense oligonucleotides, have proven effective in epigenetic research and therapy, facilitating gene expression modulation and contributing to a favorable market outlook. Moreover, collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become crucial drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborative efforts are expected to fuel the regional market over the forecasted period.

Japan Oligonucleotide Synthesis Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, application, and end use.

Product Insights:

  • Synthesized Oligonucleotide Products
  • Reagents
  • Equipment
  • Services

The report has provided a detailed breakup and analysis of the market based on the product. This includes synthesized oligonucleotide products, reagents, equipment, and services.

Application Insights:

  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In-Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in-situ hybridization (FISH), antisense oligonucleotides, and others.

End Use Insights:

  • Pharmaceutical and Biotechnology Companies
  • Hospital and Diagnostic Laboratories
  • Academic Research Institutes

The report has provided a detailed breakup and analysis of the market based on the end use. This includes pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and academic research institutes.

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan oligonucleotide synthesis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan oligonucleotide synthesis market?
  • What is the breakup of the Japan oligonucleotide synthesis market on the basis of product?
  • What is the breakup of the Japan oligonucleotide synthesis market on the basis of application?
  • What is the breakup of the Japan oligonucleotide synthesis market on the basis of end use?
  • What are the various stages in the value chain of the Japan oligonucleotide synthesis market?
  • What are the key driving factors and challenges in the Japan oligonucleotide synthesis?
  • What is the structure of the Japan oligonucleotide synthesis market and who are the key players?
  • What is the degree of competition in the Japan oligonucleotide synthesis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Oligonucleotide Synthesis Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Oligonucleotide Synthesis Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Oligonucleotide Synthesis Market - Breakup by Product

  • 6.1 Synthesized Oligonucleotide Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Reagents
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Equipment
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)
  • 6.4 Services
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2018-2023)
    • 6.4.3 Market Forecast (2024-2032)

7 Japan Oligonucleotide Synthesis Market - Breakup by Application

  • 7.1 PCR Primers
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 PCR Assays and Panels
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Sequencing
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 DNA Microarrays
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Fluorescence In-Situ Hybridization (FISH)
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2018-2023)
    • 7.5.3 Market Forecast (2024-2032)
  • 7.6 Antisense Oligonucleotides
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2018-2023)
    • 7.6.3 Market Forecast (2024-2032)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2018-2023)
    • 7.7.2 Market Forecast (2024-2032)

8 Japan Oligonucleotide Synthesis Market - Breakup by End Use

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Hospital and Diagnostic Laboratories
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Academic Research Institutes
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)

9 Japan Oligonucleotide Synthesis Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End Use
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2024-2032)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End Use
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2024-2032)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End Use
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2024-2032)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2018-2023)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End Use
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2024-2032)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2018-2023)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End Use
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2024-2032)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2018-2023)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End Use
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2024-2032)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2018-2023)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End Use
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2024-2032)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2018-2023)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End Use
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2024-2032)

10 Japan Oligonucleotide Synthesis Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

12 Japan Oligonucleotide Synthesis Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix